Spectral subClinical Research scientist reports Covid 2019 as a potential target for Electromagnetic-Q Spectrum (EMQS) therapy

24 March 2020 Interview with Spectral subClinical Research's scientist professor J. Dumanov upon his return from EU medical conferences and scientific meetings (Milan, Lugano, Geneva...) during the upstart of Covid pandemic was called upon to participate in Covid Corona 2019 research studies and review. Dumanov a highly integrated clinical molecular biologist and state and industry licensed electronics engineering specialist in communications technology explained how the novel corona Covid 2019 as understood may possibly be a target by a new EMS-Q therapeutic method currently under study and development.

During these times of the SARS Covid 2019 pandemic Spectral electro biologist and scientists fully understanding the role of virus in human and animal systems and the role of EMS-Q and especially 2-3-4-5G fields recognize that many families are clustered within their residences wherein health risk exposures from differing origins including biological, toxicological, and electromagnetic radiation elements exposure when present may increase due to many factors in their changed indoor activity.

Under the circumstances EMF EMR RF of the EMS-Q exposure may become more clinically indicated and diagnosed in our patients with neurological disorders such as MS and may be evidenced as present if suspect based upon referenced sympthomology. Dumanov reports that both mammalian viral activity and cell death may increase in the presence of electromagnetic fields and proposes that elements of the EMS-Q may in fact provide a potential highly effective mechanism for anti-viral Covid therapy.

FOR EMF LICENESED ELECTRONIC ENGINEERS AND MEDICAL EXPERTS VISIT THESE SITES:

FOR SCRANTON STROUDSBURG DELAWARE VALLEY POCONO AREA

FOR NEW YORK CITY HUDSON VALLEY CONNECTICUT WESTCHESTER DUTCHESS ROCKLAND SULLIVN AND ORANGE COUNTY

FOR NEW JERSEY NEW YORK CITY STATEN ISLAND WARREN BERGEN HUDSON COUNTY